218 related articles for article (PubMed ID: 31955451)
1. Diffuse large B-cell lymphoma carrying t(9;14)(p13;q32)/PAX5-immunoglobulin heavy chain gene is characterized by nuclear positivity of MUM1 and PAX5 by immunohistochemistry.
Ohno H; Nakagawa M; Kishimori C; Fukutsuka K; Maekawa F; Takeoka K; Hayashida M; Sakamoto S; Akasaka T; Honjo G
Hematol Oncol; 2020 Apr; 38(2):171-180. PubMed ID: 31955451
[TBL] [Abstract][Full Text] [Related]
2. t(9;14)(p13;q32)/PAX5-IGH translocation as a secondary cytogenetic abnormality in diffuse large B-cell lymphoma.
Ohno H; Takeoka K; Kishimori C; Nakagawa M; Fukutsuka K; Maekawa F; Hayashida M; Akasaka T; Sumiyoshi S
J Clin Exp Hematop; 2021 Dec; 61(4):216-220. PubMed ID: 34707037
[TBL] [Abstract][Full Text] [Related]
3. PAX5-positive plasma cell myeloma with t(9;14;11)(p13;q32;q13), a novel complex variant translocation of t(11;14)(q13;q32) and t(9;14)(p13;q32).
Sato K; Sakai H; Kato M; Nishio Y; Tsuruoka Y; Uemura Y; Yokoi S; Saito T; Matsunawa M; Suzuki Y; Isobe Y; Inoue Y; Takahashi M; Miura I
Int J Hematol; 2015 Jun; 101(6):608-11. PubMed ID: 25633778
[TBL] [Abstract][Full Text] [Related]
4. Expression of the PAX5/BSAP transcription factor in haematological tumour cells and further molecular characterization of the t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Hamada T; Yonetani N; Ueda C; Maesako Y; Akasaka H; Akasaka T; Ohno H; Kawakami K; Amakawa R; Okuma M
Br J Haematol; 1998 Aug; 102(3):691-700. PubMed ID: 9722295
[TBL] [Abstract][Full Text] [Related]
5. In vitro Epstein-Barr virus-immortalized lymphoma cell line carrying t(9;14)(p13;q32) chromosome abnormality, derived from splenic lymphoma with villous lymphocytes.
Daibata M; Taguchi T; Nemoto Y; Iwasaki S; Ohtsuki Y; Taguchi H
Int J Cancer; 2006 Jan; 118(2):513-7. PubMed ID: 16049984
[TBL] [Abstract][Full Text] [Related]
6. Oncogenic role of Pax5 in the T-lymphoid lineage upon ectopic expression from the immunoglobulin heavy-chain locus.
Souabni A; Jochum W; Busslinger M
Blood; 2007 Jan; 109(1):281-9. PubMed ID: 16968900
[TBL] [Abstract][Full Text] [Related]
7. The t(9;14)(p13;q32) chromosomal translocation associated with lymphoplasmacytoid lymphoma involves the PAX-5 gene.
Iida S; Rao PH; Nallasivam P; Hibshoosh H; Butler M; Louie DC; Dyomin V; Ohno H; Chaganti RS; Dalla-Favera R
Blood; 1996 Dec; 88(11):4110-7. PubMed ID: 8943844
[TBL] [Abstract][Full Text] [Related]
8. Translocations involving the immunoglobulin heavy chain gene locus predict better survival in gastric diffuse large B-cell lymphoma.
Nakamura S; Ye H; Bacon CM; Goatly A; Liu H; Kerr L; Banham AH; Streubel B; Yao T; Tsuneyoshi M; Savio A; Takeshita M; Dartigues P; Ruskoné-Fourmestraux A; Matsumoto T; Iida M; Du MQ
Clin Cancer Res; 2008 May; 14(10):3002-10. PubMed ID: 18445693
[TBL] [Abstract][Full Text] [Related]
9. Deregulated PAX-5 transcription from a translocated IgH promoter in marginal zone lymphoma.
Morrison AM; Jäger U; Chott A; Schebesta M; Haas OA; Busslinger M
Blood; 1998 Nov; 92(10):3865-78. PubMed ID: 9808580
[TBL] [Abstract][Full Text] [Related]
10. A novel five-way translocation, t(3;9;13;8;14)(q27;p13;q32;q24;q32), with concurrent MYC and BCL6 rearrangements in a primary bone marrow B-cell lymphoma.
Yamamoto K; Matsuoka H; Yakushijin K; Funakoshi Y; Okamura A; Hayashi Y; Minami H
Cancer Genet; 2011 Sep; 204(9):501-6. PubMed ID: 22018272
[TBL] [Abstract][Full Text] [Related]
11. Deregulation of PAX-5 by translocation of the Emu enhancer of the IgH locus adjacent to two alternative PAX-5 promoters in a diffuse large-cell lymphoma.
Busslinger M; Klix N; Pfeffer P; Graninger PG; Kozmik Z
Proc Natl Acad Sci U S A; 1996 Jun; 93(12):6129-34. PubMed ID: 8650231
[TBL] [Abstract][Full Text] [Related]
12. Characterization of de novo diffuse large B-cell lymphoma with a translocation of c-myc and immunoglobulin genes.
Kikuchi A; Nakamura N; Kuze T; Sasaki Y; Abe M; Ohno H; Akasaka T; Nakamura S; Ohshima K; Ando K
Leuk Res; 2008 Aug; 32(8):1176-82. PubMed ID: 18460403
[TBL] [Abstract][Full Text] [Related]
13. Diverse B-cell tumors associated with t(14;19)(q32;q13)/IGH::BCL3 identified by G-banding and fluorescence in situ hybridization.
Ohno H; Maekawa F; Hayashida M; Nakagawa M; Fukutsuka K; Matsumura M; Takeoka K; Maruyama W; Ukyo N; Sumiyoshi S; Tanaka Y; Haga H
J Clin Exp Hematop; 2024; 64(1):21-31. PubMed ID: 38538317
[TBL] [Abstract][Full Text] [Related]
14. IRF8 is associated with germinal center B-cell-like type of diffuse large B-cell lymphoma and exceptionally involved in translocation t(14;16)(q32.33;q24.1).
Tinguely M; Thies S; Frigerio S; Reineke T; Korol D; Zimmermann DR
Leuk Lymphoma; 2014 Jan; 55(1):136-42. PubMed ID: 23573829
[TBL] [Abstract][Full Text] [Related]
15. Lack of PAX5 rearrangements in lymphoplasmacytic lymphomas: reassessing the reported association with t(9;14).
Cook JR; Aguilera NI; Reshmi-Skarja S; Huang X; Yu Z; Gollin SM; Abbondanzo SL; Swerdlow SH
Hum Pathol; 2004 Apr; 35(4):447-54. PubMed ID: 15116325
[TBL] [Abstract][Full Text] [Related]
16. Interphase detection of BCL6/IgH fusion gene in non-Hodgkin lymphoma by fluorescence in situ hybridization.
Ueda Y; Nishida K; Miki T; Horiike S; Kaneko H; Yokota S; Misawa S; Abe T; Kashima K; Taniwaki M
Cancer Genet Cytogenet; 1997 Dec; 99(2):102-7. PubMed ID: 9398863
[TBL] [Abstract][Full Text] [Related]
17. Low-grade B-Cell lymphomas with plasmacytic differentiation lack PAX5 gene rearrangements.
George TI; Wrede JE; Bangs CD; Cherry AM; Warnke RA; Arber DA
J Mol Diagn; 2005 Aug; 7(3):346-51. PubMed ID: 16049306
[TBL] [Abstract][Full Text] [Related]
18. t(14;18)(q32;q21) involving IGH and MALT1 is uncommon in cutaneous MALT lymphomas and primary cutaneous diffuse large B-cell lymphomas.
Wongchaowart NT; Kim B; Hsi ED; Swerdlow SH; Tubbs RR; Cook JR
J Cutan Pathol; 2006 Apr; 33(4):286-92. PubMed ID: 16630178
[TBL] [Abstract][Full Text] [Related]
19. The t(9;14)(p13;q32) translocation in B-cell non-Hodgkin's lymphoma.
Ohno H; Ueda C; Akasaka T
Leuk Lymphoma; 2000 Feb; 36(5-6):435-45. PubMed ID: 10784387
[TBL] [Abstract][Full Text] [Related]
20. MUM1/IRF4 expression as a frequent event in mature lymphoid malignancies.
Tsuboi K; Iida S; Inagaki H; Kato M; Hayami Y; Hanamura I; Miura K; Harada S; Kikuchi M; Komatsu H; Banno S; Wakita A; Nakamura S; Eimoto T; Ueda R
Leukemia; 2000 Mar; 14(3):449-56. PubMed ID: 10720141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]